Is there room for another personal genomics company? That's the question Daniel MacArthur asks on the news that Australia-based Lumigenix recently launched and will offer its genetic test for $470, slightly more than competitor 23andMe. The biggest obstacles, he writes, are its second-to-market status and the anti-genetic testing climate in Australia.